Emergent BioSolutions Executive Pay Revealed
Ticker: EBS · Form: DEF 14A · Filed: Mar 21, 2025 · CIK: 1367644
| Field | Detail |
|---|---|
| Company | Emergent Biosolutions Inc. (EBS) |
| Form Type | DEF 14A |
| Filed Date | Mar 21, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement, governance
Related Tickers: EBS
TL;DR
Emergent Bio exec pay details for 2024 are out, showing compensation for Miller & Papa Members.
AI Summary
Emergent BioSolutions Inc. filed its DEF 14A on March 21, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on compensation for key personnel such as Miller Member and Papa Member, with compensation data spanning from 2020 to 2024. It also references equity awards and adjustments for performance-based compensation.
Why It Matters
This filing provides transparency into how Emergent BioSolutions compensates its top executives, which can influence investor perception and corporate governance.
Risk Assessment
Risk Level: medium — DEF 14A filings often contain information about executive compensation and corporate governance, which can be material to investors and signal potential risks or opportunities.
Key Numbers
- 2024 — Fiscal Year (Reporting period for executive compensation)
- 2020-2024 — Compensation Data Range (Historical executive compensation information provided)
Key Players & Entities
- Emergent BioSolutions Inc. (company) — Filer of the DEF 14A
- Miller Member (person) — Executive compensation recipient
- Papa Member (person) — Executive compensation recipient
- 2024-12-31 (date) — Fiscal year end
- 20250321 (date) — Filing date
FAQ
What was the total compensation for Emergent BioSolutions' named executive officers in 2024?
The filing provides compensation data for the fiscal year ending December 31, 2024, for individuals identified as Miller Member and Papa Member, but specific total dollar amounts are not detailed in this excerpt.
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted on March 21, 2025.
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is filed by companies to solicit proxies from shareholders for an upcoming annual or special meeting.
Which fiscal year does this filing primarily cover regarding compensation?
This filing primarily covers the fiscal year ending December 31, 2024, with historical data provided for previous years.
What type of compensation elements are mentioned in the filing excerpt?
The filing excerpt mentions equity awards, summary compensation tables, and adjustments for performance-based compensation.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 21, 2025 by Miller Member regarding Emergent BioSolutions Inc. (EBS).